Evidence map›Paper›PMID 38063922›Full record

Trial reportNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2024

Efficacy of transauricular vagus nerve stimulation for the treatment of chemotherapy-induced painful peripheral neuropathy: a randomized controlled exploratory study.

Yifan Yang, Ran Zhang, Zhifang Zhong, Jun Li, Yi Feng

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07593365 (Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain), which is not on this map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07593365 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain

TypeinterventionalSponsorPeking University People's HospitalRan2026 to 2029Enrolled216ConditionsAromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Pain AlleviationArmstranscutaneous auricular vagus nerve stimulation, sham stimulation
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. [Research progress on vagus nerve stimulation in the treatment of chronic pain].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yifan Yang *Department of Pain Medicine, Peking University People's Hospital, Beijing, People's Republic of China.
Ran Zhang *Department of Anesthesiology, Peking University People's Hospital, Beijing, People's Republic of China.
Zhifang ZhongDepartment of Pain Medicine, Peking University People's Hospital, Beijing, People's Republic of China.
Jun Li *Department of Pain Medicine, Peking University People's Hospital, Beijing, People's Republic of China. clivia.li@163.com.ORCID http://orcid.org/0009-0002-7373-3531
Yi Feng *Department of Pain Medicine, Peking University People's Hospital, Beijing, People's Republic of China. fengyi@pkuph.edu.cn.
Peking University · CN

Funding

Peking University People's Hospital Scientific Research Development Funds. Project (RDJ2022-25)
6 · The paper itself

Abstract

backgroundChemotherapy-induced painful peripheral neuropathy (CIPN) is a common adverse event in cancer patients, and there is still a lack of effective treatment. Transauricular vagal nerve stimulation (taVNS) is a minimally invasive treatment, but there are few reports regarding its efficacy for CIPN.

objectiveTo investigate the efficacy and possible mechanism of taVNS in patients with CIPN.

methodsTwenty-seven patients with CIPN were randomly divided into a taVNS group (n = 14) and a sham stimulation (SS) group (n = 13). A numerical rating scale (NRS) for pain, NCICTCAE 4.0 (neurotoxicity classification), quantitative sensory test (QST), Short-Form-Health Survey-12 (SF-12), and Athens Insomnia Scale (AIS) were administered before the intervention (D-10) and on the day after the intervention (D0), and the inflammatory cytokines in plasma were also measured. The NRS, NCI-CTCAE 4.0, SF-12, and AIS were administered again at D30 and D90.

resultsCompared with the SS group, the NRS and AIS in the taVNS group were significantly lower at D0. The impact lasted until D30. There were no statistically significant differences in the NRS and AIS between the 2 groups at D90. On D30, the mental component score of the SF-12 was significantly higher in the taVNS group than in the SS group. No adverse events were found. There was no significant difference in QST and plasma inflammatory cytokines between the 2 groups.

conclusiontaVNS can relieve chemotherapy-induced neuropathic pain in the short term, can improve sleep status and quality of life, and is expected to become a novel clinical treatment method for CIPN.

Indexed as

Antineoplastic AgentsNeuralgiaVagus Nerve StimulationCytokinesHumansQuality of LifeVagus NerveAntineoplastic AgentsCytokinesChemotherapy-induced peripheral neuropathy (CIPN)Transauricular vagus nerve stimulation (taVNS)Vagus nerve stimulation (VNS)

Identifiers

PMID38063922
OpenAlexW4389478456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.